Schonfeld Strategic Advisors’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-28,800	Closed	-$138K	–	3044
2021 Q4	$138K	Buy	28,800 +14,100	+96%	+$91K	﹤0.01%	1833
2021 Q3	$112K	Buy	+14,700	New	+$94.1K	﹤0.01%	1906
2021 Q2	–	Sell	-48,522	Closed	-$378K	–	2430
2021 Q1	$378K	Sell	48,522 -14,746	-23%	-$147K	﹤0.01%	1246
2020 Q4	$585K	Sell	63,268 -38,832	-38%	-$338K	0.01%	993
2020 Q3	$704K	Buy	102,100 +29,500	+41%	+$179K	0.01%	810
2020 Q2	$476K	Buy	+72,600	New	+$262K	0.01%	822

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schonfeld Strategic Advisors's SURF Position: Q1 2022 in Review

Schonfeld Strategic Advisors sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2022, closing a stake of 28,800 shares — an estimated $138K sold.

Schonfeld Strategic Advisors first reported a position in SURF in Q2 2020 and held it in 6 quarters. The position peaked at $704K in Q3 2020. 103 funds tracked by Wall St. Rank hold SURF as of Q1 2022.

Schonfeld Strategic Advisors reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 28,800 Surface Oncology, Inc. Common Stock shares in Q1 2022, an estimated $138K.
Schonfeld Strategic Advisors first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
Schonfeld Strategic Advisors's Surface Oncology, Inc. Common Stock position peaked at $704K in Q3 2020.
103 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2022, filed 16 May 2022.